Literature DB >> 25004968

Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300.

Prasenjit Bhaumik1, Jamaine Davis1, Joseph E Tropea2, Scott Cherry2, Peter F Johnson3, Maria Miller1.   

Abstract

Members of the C/EBP family of transcription factors bind to the Taz2 domain of p300/CBP and mediate its phosphorylation through the recruitment of specific kinases. Short sequence motifs termed homology boxes A and B, which comprise their minimal transactivation domains (TADs), are conserved between C/EBP activators and are necessary for specific p300/CBP binding. A possible mode of interaction between C/EBP TADs and the p300 Taz2 domain was implied by the crystal structure of a chimeric protein composed of residues 1723-1818 of p300 Taz2 and residues 37-61 of C/EBPℇ. The segment corresponding to the C/EBPℇ TAD forms two orthogonally disposed helices connected by a short linker and interacts with the core structure of Taz2 from a symmetry-related molecule. It is proposed that other members of the C/EBP family interact with the Taz2 domain in the same manner. The position of the C/EBPℇ peptide on the Taz2 protein interaction surface suggests that the N-termini of C/EBP proteins are unbound in the C/EBP-p300 Taz2 complex. This observation is in agreement with the known location of the docking site of protein kinase HIPK2 in the C/EBPβ N-terminus, which associates with the C/EBPβ-p300 complex.

Entities:  

Keywords:  HIPK2; ligand binding; molecular recognition; transcription

Mesh:

Substances:

Year:  2014        PMID: 25004968      PMCID: PMC4089485          DOI: 10.1107/S1399004714009262

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  34 in total

Review 1.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

2.  Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.

Authors:  Yukiko Aikawa; Lan Anh Nguyen; Kyoichi Isono; Nobuyuki Takakura; Yusuke Tagata; M Lienhard Schmitz; Haruhiko Koseki; Issay Kitabayashi
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

3.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.

Authors:  Xinmin Zhang; Duncan T Odom; Seung-Hoi Koo; Michael D Conkright; Gianluca Canettieri; Jennifer Best; Huaming Chen; Richard Jenner; Elizabeth Herbolsheimer; Elizabeth Jacobsen; Shilpa Kadam; Joseph R Ecker; Beverly Emerson; John B Hogenesch; Terry Unterman; Richard A Young; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

4.  v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.

Authors:  S Steinmann; K Schulte; K Beck; S Chachra; T Bujnicki; K-H Klempnauer
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

5.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation.

Authors:  Krisztián A Kovács; Myriam Steinmann; Pierre J Magistretti; Olivier Halfon; Jean-René Cardinaux
Journal:  J Biol Chem       Date:  2003-07-11       Impact factor: 5.157

8.  Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).

Authors:  Simone Steinmann; Anna Coulibaly; Johanna Ohnheiser; Anke Jakobs; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  13 in total

1.  Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.

Authors:  Lisa M Miller Jenkins; Hanqiao Feng; Stewart R Durell; Harichandra D Tagad; Sharlyn J Mazur; Joseph E Tropea; Yawen Bai; Ettore Appella
Journal:  Biochemistry       Date:  2015-03-16       Impact factor: 3.162

2.  The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.

Authors:  Ariane L Jansma; Maria A Martinez-Yamout; Rong Liao; Peiqing Sun; H Jane Dyson; Peter E Wright
Journal:  J Mol Biol       Date:  2014-11-01       Impact factor: 5.469

Review 3.  Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.

Authors:  H Jane Dyson; Peter E Wright
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

4.  Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.

Authors:  Anke Jakobs; Simone Steinmann; Sarah Marie Henrich; Thomas J Schmidt; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2016-11-01       Impact factor: 5.157

5.  Characterization of the High-Affinity Fuzzy Complex between the Disordered Domain of the E7 Oncoprotein from High-Risk HPV and the TAZ2 Domain of CBP.

Authors:  Michael W Risør; Ariane L Jansma; Natasha Medici; Brittany Thomas; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2021-12-14       Impact factor: 3.162

6.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

7.  Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.

Authors:  Alexander S Krois; Josephine C Ferreon; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

Review 8.  Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.

Authors:  Thomas J Schmidt; Karl-Heinz Klempnauer
Journal:  Molecules       Date:  2022-03-23       Impact factor: 4.411

9.  K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression.

Authors:  Han-Tsang Wu; Yi-Chih Kuo; Jung-Jyh Hung; Chi-Hung Huang; Wei-Yi Chen; Teh-Ying Chou; Yeh Chen; Yi-Ju Chen; Yu-Ju Chen; Wei-Chung Cheng; Shu-Chun Teng; Kou-Juey Wu
Journal:  Nat Commun       Date:  2016-12-09       Impact factor: 14.919

10.  PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

Authors:  Evelyn Ramberger; Valeria Sapozhnikova; Elisabeth Kowenz-Leutz; Karin Zimmermann; Nathalie Nicot; Petr V Nazarov; Daniel Perez-Hernandez; Ulf Reimer; Philipp Mertins; Gunnar Dittmar; Achim Leutz
Journal:  iScience       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.